The C242T p22phox polymorphism and endothelium-dependent vasodilation in subjects with hypercholesterolaemia

Clinical Science

Volumn 105, Issue 1, 2003, Pages 97-103

  Schneider, Markus P ^a   Hilgers, Karl F ^a   Huang, Yale ^a   Delles, Christian ^a   John, Stefan ^a   Oehmer, Sebastian ^a   Schmieder, Roland E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Basal vascular tone; Endothelium dependent vasodilation; NAD(P)H oxidase; Oxidative stress; p22phox polymorphism

Indexed keywords

ACETYLCHOLINE; CHOLESTEROL; N(G) METHYLARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL TONE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYBA P22PHOX GENE; DISEASE ASSOCIATION; FEMALE; FOREARM BLOOD FLOW; GENDER; GENE; GENETIC CODE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION; VEIN;

ACETYLCHOLINE; ADULT; ANALYSIS OF VARIANCE; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; GENOTYPE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NADPH DEHYDROGENASE; NADPH OXIDASE; NITROPRUSSIDE; OMEGA-N-METHYLARGININE; OXIDATIVE STRESS; PHOSPHOPROTEINS; POLYMORPHISM, GENETIC; REGIONAL BLOOD FLOW; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 0037664695     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20030003     Document Type: Article

References (31)

1. Solzbach, U., Hornig, B., Jeserich, M. and Just, H. (1997) Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 96, 1513-1519
2. Perticone, F., Ceravolo, R., Maio, R. et al. (2000) Effects of atorvastatin and vitamin C on endothelial function in hypercholesterolemic patients. Atherosclerosis 152, 511-518
3. Chowienczyk, P. J., Brett, S. E., Gopaul, N. K. et al. (2000) Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type II diabetes. Diabetologica 43, 874-877
4. Levine, G. N., Frei, B., Koulouris, S. N., Keaney, J. F. and Vita, J. A. (1996) Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 93, 1107-1113
5. Rajagopalan, S., Kurz, S., Münzel, T. et al. (1996) Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contributions to alterations in vascular tone. J. Clin. Invest. 97, 1916-1923
6. Mohazzab, K. M. and Wolin, M. S. (1994) Sites of superoxide anion production detected by lucigenin in calf pulmonary artery smooth muscle. Am. J. Physiol. 267, L815-L822
7. Pagano, P. J., Ito, Y., Tornheim, K., Gallop, P. M., Tauber, A. I. and Cohen, R. A. (1995) An NADPH oxidase superoxide-generating system in the rabbit aorta. Am. J. Physiol. 268, H2274-H2280
8. Guzik, T. J., West, N. E. J., Black, E. et al. (2000) Vascular superoxide production by NAD(P)H oxidase. Association with endothelial dysfunction and clinical risk factors. Circ. Res. 86, 85-90
9. Hamilton, C. A., Brosnan, M. J., Al-Benna, S., Berg, G. and Dominiczak, A.F. (2002) NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension 40, 755-762
10. Inoue, N., Kawashima, S., Kanazawa, K., Yamada, S., Akita, H. and Yokoyama, M. (1998) Polymorphism of the NADH/NADPH oxidase p22phox gene in patients with coronary artery disease. Circulation 97, 135-137
11. Cai, H., Juarte, N., Wilcken, D. E. et al. (1999) NADH/NADPH oxidase p22phox C242T polymorphism and coronary artery disease in the Australian population. Eur. J. Clin. Invest. 29, 744-748
12. Ito, D., Murata, M., Watanabe K. et al. (2000) C242T polymorphism of NADPH oxidase p22 phox gene and ischemic cerebrovascular disease in the Japanese population. Stroke 31, 936-939
13. Cahilly, C., Ballantyne, C. M., Lim, D. S., Gotto, A. and Marian, A. J. (2000) A variant of p22phox, involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ. Res. 86, 391-395
14. Li, A., Prasad, A., Mincemoyer, R. et al. (1999) Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function. Am. J. Med. Genet. 86, 57-61
15. Gardemann, A., Mages, P., Katz, N., Tillmanns, H. and Haberbosch, W. (1999) The p22phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis 145, 315-323
16. Guzik, T. J., West, N. E. J, Black, E. et al. (2000) Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 102, 1744-1747
17. Warnholtz, A., Nickenig, G., Schulz, E. et al. (1999) Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis. Circulation 99, 2027-2033
18. Rueckschloss, U., Galle, J., Holtz, J., Zerkowski, H. R. and Morawietz, H. (2001) Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethyglutaryl coenzyme A reductase inhibitor therapy. Circulation 104, 1767-1772
19. John, S., Schlaich, M., Langenfeld, M. et al. (1998) Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study. Circulation 98, 211-216
20. Norusis, M. J. (1993) SPSS for Windows: Advanced Statistics Release 6.0, SPSS Inc., Chicago
21. Griendling, K. K. and Ushio-Fukai, M. (1998) Redox control of vascular smooth muscle proliferation. J. Lab. Clin. Med. 132, 9-15
22. Griendling, K. K., Sorescu, D. and Ushio-Fukai, M. (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86, 494-501
23. Stanger, O., Renner, W., Khoschsorur, G., Rigler, B. and Wascher, T. C. (2001) NADH/NADPH oxidase p22phox C242T polymorphism and lipid peroxidation in coronary artery disease. Clin. Physiol. 21, 718-722
24. Schächinger, V., Brittcn, M. B. and Zeiher, A. M. (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101, 1899-1906
25. Suwaidi, J. A., Hamasaki, S., Higano, S. T., Nishimura, R. A., Holmes, D. R. and Lerman, A. (2000) Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101, 948-954
26. Perticone, F., Ceravolo, R., Pujia, A. et al. (2001) Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104, 191-196
27. Stroes, E. S., Koomans, H. A., de Bruin, T. W. A. and Rabelink, T. J. (1995) Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 346, 467-471
28. 2- and systolic blood pressure in mice. Circ. Res. 89, 408-414
29. Irani, K. (2000) Oxidant signaling in vascular cell growth, death, and survival. Circ. Res. 87, 179-183
30. Azumi, H., Inoue, N., Takeshita, S. et al. (1999) Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation 100, 1494-1498
31. Lifton, R. P. (1995) Genetic determinants of human hypertension. Proc. Natl. Acad. Sci. U.S.A. 92, 8545-8551